Argus Scientific Corp
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Argus Scientific Corp - overview
Established
2015
Location
Suzhou, Jiangsu, China
Primary Industry
Medical Devices & Equipment
About
Based in China and established in 2015, Argus Scientific Corp is a medical device company that focuses on developing and marketing medical equipment and disposable medical catheters for clinical applications. The company was founded by a team of fiber optics experts and medical device, who has rich experience in technology and development. The company raised secured Pre-A, series A, and series B funding in excess of $10 million. The company has R&D center and production plant in California, Suzhou Industrial Park and Wuhan Optics Valley.
The company provides optical coherence tomography (OCT) system. It has independently developed the Arugs Clarity (OCT) system, and Argus Nopurgetm disposable imaging catheter. The Argus Nopurgetm has obtained the registration certificate issued by the National Food and Drug Administration (NMPA) in March 2021. The company plans to expand marketing share in OCT and disposable medical catheter fields.
Current Investors
Oriza Holdings, Detong Capital, CASH Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare IT, Medical Devices & Equipment
Website
www.argus-sci.com
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.